Asthma

Budesonide/formoterol resulted in a statistically significantly greater improvement than budesonide alone in asthma patients age 12 and under.

Inhaled combination of budesonide and formoterol shows promise treating asthma in children aged 6 to 12.

The results of a recent study indicate that children with asthma may be more likely to develop obesity than those without the respiratory condition.

Omalizumab prevented symptoms of inducible urticaria.​

Patients who have asthma and who are also obese carry a heavy burden.

The Allergy & Asthma Network and Avella Specialty Pharmacy have released a new white paper to underscore the significant risks related to latex allergies and the use of latex in healthcare.

Treatment with Accolate or Singulair could prevent influenza pneumonia infections.

Children born to mothers with low vitamin E levels may be more likely to require asthma medications.

Depletion of a specific protein can lead to a respiratory symptoms of asthma.

Relvar Ellipta demonstrated non-inferiority to SeretideAccuhaler in asthma therapy.

The results showed all participants responded to omega-3 fatty acids to some degree, with a reduction in IgE production.

Treatment with omega-3 reduces levels of IgE antibodies to reduce the risk of asthma flare-ups.

The FDA has expanded the indication of Boehringer Ingelheim Pharmaceuticals’ Spiriva Respimat (tiotropium bromide).

Over the years, a number of landmark clinical studies on asthma have been published, shaping how we treat the disease today.

Alcoholism causes cravings that often cause individuals to relapse.

Have scientists found a new drug that could curb alcohol cravings and treat addiction?

The FDA has approved Teva’s newest asthma treatment for adolescent and adult patients.

Both RespiClick inhalers were observed to improve lung function in patients with asthma.

Officials with AstraZeneca recently announced that the FDA has expanded the indication of its 80/4.5 mcg budesonide and formoterol fumarate dihydrate inhalation aerosol (Symbicort), approving the drug for the treatment of asthma in patients aged 6 to 12 years.

Children born to mothers who took heartburn medication were more likely to visit the physician for asthma symptoms.

Individuals enrolled in high-deductible health plans face thousands in out of pocket costs.

Individuals with chronic diseases and high-deductible health insurance spend more than 10% on out-of-pocket costs.

A combination of oxaprozin and salbutamol would provide patients with an easier treatment regimen.

Due to the high cost of biologic drugs for severe asthma, it is vital for the most efficient drug to be used for each patient.

Healthcare support staff and community and social services workers led all occupations in rates of asthma occurrence.

An initiative that lowered copays for prescription drugs also lowered hospitalizations by 40%

Patients who discontinued long-term treatment with omalizumab more likely to experience severe asthma exacerbation.

Top news of the day from across the health care landscape.

Benralizumab reduced the annual rate of asthma exacerbations by up to 51%.

Cromolyn sodium associated with reduced liver fibrosis.